Novel radionuclide therapy found to be more effective in NET patients
The study shows modifying the standard of care for late-stage…
The study shows modifying the standard of care for late-stage neuroendocrine tumours (NETs) with Evans blue dye makes the treatment more effective and potentially less toxic.